Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Kintara Therapeutics, Inc. (DMPI)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsJun-30-22Jun-30-21Jun-30-20Jun-30-19Jun-30-18Jun-30-17Jun-30-16Jun-30-15
   10-K10-K10-K10-K10-K10-K10-K10-K
Net income  -22.7-38.3-9.18.1-11.3-8.9-9.1-4.3
Depreciation and amortization   [+]  0.00.00.00.00.0 
Stock-based compensation    0.51.00.50.10.40.2
Change in working capital  7.28.61.93.73.41.91.31.9
Other operating activities  -4.910.8-1.2-19.1-2.5-1.22.2-1.6
Cash from operations  -20.4-18.9-7.9-6.3-9.9-8.0-5.1-3.9
   
Capital expenditures   [+]0.10.10.10.10.10.10.00.0
Other cash from investing   0.9  -0.1-0.1-0.1 
Cash from investing  0.11.00.10.10.00.00.00.0
   
Option exercises   0.1      
Financing costs    0.0    -0.6
Other cash from financing  21.626.16.64.19.28.59.60.3
Cash from financing  21.626.06.64.19.28.59.60.8
   
Free cash flow  -20.4-18.9-7.9-6.3-9.9-8.0-5.1-3.9
        Per share (diluted)  ($0.42)($0.73)($0.75)($2.43)($4.68)($0.66)($0.47)($0.40)
   

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy